Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement
Journal of Medicinal Chemistry · 13.11.2025 · 68 (21) · 23532-23553
DOI: 10.1021/acs.jmedchem.5c02412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 15.10.2025. Verfasst von Juraj Velcicky und 31 weiteren Autor:innen. Beteiligte Einrichtung: Novartis BioMedical Research, CH-4002 Basel, Switzerland. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Indoles, Drug Discovery, Pyridazines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: NovartisNovartis BioMedical Research Inc.
Abstract (Originalsprache)
NLRP3 is a molecular sensor present in innate immune cells which recognizes a variety of danger signals such as MSU, ATP, or Aβ. Upon activation, it seeds a protein complex termed the inflammasome, which leads to secretion of the proinflammatory cytokines IL-1β and IL-18 and initiates pyroptotic cell death. NLRP3 inflammasome activation has been associated with a wide range of diseases including atherosclerosis, gout, and cancer. In this publication, we describe the replacement of the phenol moiety with indoles in the recently described pyridazine scaffold. This replacement required a shift of the hydrogen bond donor from the “ortho” to the “meta” position, relative to the pyridazine ring. Initial indole analog 7 demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. Decreasing lipophilicity led to the discovery of NP3-742, demonstrating a favorable overall profile including diminished hERG inhibition and in vivo efficacy in a mouse peritonitis model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Novartis BioMedical Research, CH-4002 Basel, Switzerland.
ORCID-Profile: Juraj Velcicky, Jean-Baptiste Langlois, Daniela Angst, Janet Dawson, Rainer Machauer, Christopher J Farady, Angela Mackay
Förderung
- NovartisNovartis BioMedical Research Inc
Zitieren
APA
Velcicky, J., Langlois, J. B., Wright, M., Janser, P., Angst, D., Arnold, C., Beltz, K., Brenneisen, S., Dubois, C., Dawson, J., Fischer, C., Gommermann, N., Heizmann, A., Ilic, S., Machauer, R., Maschlej, M., Monnerat, S., Pflieger, D., Ristov, J., …, & Mackay, A. (2025). Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement. Journal of Medicinal Chemistry, 68(21), 23532-23553. https://doi.org/10.1021/acs.jmedchem.5c02412
Vancouver
Velcicky J, Langlois JB, Wright M, Janser P, Angst D, Arnold C, et al. Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement. Journal of Medicinal Chemistry. 2025;68(21):23532-23553. doi:10.1021/acs.jmedchem.5c02412
BibTeX
@article{Velcicky2025,
author = {Velcicky, Juraj and Langlois, Jean-Baptiste and Wright, Michael and Janser, Philipp and Angst, Daniela and Arnold, Christelle and Beltz, Karen and Brenneisen, Silke and Dubois, Celine and Dawson, Janet and Fischer, Christian and Gommermann, Nina and Heizmann, Andreas and Ilic, Slavica and Machauer, Rainer and Maschlej, Magdalena and Monnerat, Sarah and Pflieger, Daniel and Ristov, Jacinda and Rubert, Joelle and Schwalm, Günther and Smith, Daniel R and Srinivas, Honnappa and Steiner, Roland and Stojanovic, Aleksandar and Troxler, Thomas and Unterreiner, Adeline and Vangrevelinghe, Eric and von Burg, Nicole and Wunderlich, Jennifer and Farady, Christopher J and Mackay, Angela},
title = {Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {21},
pages = {23532--23553},
doi = {10.1021/acs.jmedchem.5c02412}
}
EUVIMED